ArisGen

ArisGen is a biotech company focusing on non-invasive peptide and protein delivery and enhanced protein therapeutics. The use of peptides and proteins as therapeutic agents is limited by shortage of effective means of delivery other than injection. Peptide and protein therapeutics are further disadvantaged as drugs if they induce an immune response and by the difficulty of achieving high bioavailability into the systemic circulation due to enzymatic degradation.

For more information, please visit www.arisgen.com